Gianpiero Lazzari

PhD, Sales Specialist - Cell & Gene Therapies

[Gianpiero Lazzari @GpLazzari]

Curious to know the opinion of different stakeholders on the most #disruptive #innovations on the horizon? Read the Q&As of this interesting roundtable. https://t.co/JjvYLETF9m

[Gianpiero Lazzari @GpLazzari]

Think you know #blooddisorders? Take our latest #EurekaBlog #quiz and find out! https://t.co/beoW8IaMes

[Gianpiero Lazzari @GpLazzari]

https://t.co/dIr2fEjVzi

[Gianpiero Lazzari @GpLazzari]

Instead of deleting genes, epigenetic editing modulates their activity. A new paper tests if it's able to undo a genetic effect of early alcohol exposure. https://t.co/1ziLk8kQ8n

[Gianpiero Lazzari @GpLazzari]

Memorial Sloan Kettering Cancer Center researchers deliver an unheard of result in rectal cancer treatment: that is, remission in all patients. https://t.co/Eg490nbBZ5

[Gianpiero Lazzari @GpLazzari]

In this new case study, ElevateBio's Mike Paglia describes how his organization is rising to the challenge of delivering advanced therapies with help from Cytiva. Read on: https://t.co/ZCncHZIAwX

#genetherapy
#celltherapy

[Gianpiero Lazzari @GpLazzari]

Global life sciences leader Cytiva is opening a new 7,400 m² manufacturing facility in Grens, Switzerland on May 31, 2022. The site will serve as a ‘Center of Excellence for Cytiva’s Cell & Gene Therapy business. Learn more: https://t.co/bY7l4YxRnJ

#celltherapy
#genetherapy

[Gianpiero Lazzari @GpLazzari]

A new, whole-genome study reveals new clues to the genetic mutations that cause cancer. https://t.co/O4qNsUHCcY

[Gianpiero Lazzari @GpLazzari]

Save the date: Join us for a live discussion to celebrate the opening of our new manufacturing site in Grens, Switzerland, featuring Mary Blenn, Catarina Flyborg, and Mark Woods. Register>>https://t.co/2TEKSRaWGa

#cellandgenetherapy
#lifesciences
#supplychain

[Gianpiero Lazzari @GpLazzari]

Good news on the horizon!

https://t.co/uVLpqZ3912

[Gianpiero Lazzari @GpLazzari]

Take another step forward in becoming an expert in the cell and gene therapy field. Register today for our free online CELLT1 course! https://t.co/esk1cHclW4

#celltherapy
#lifesciences
#biotechnology

[Gianpiero Lazzari @GpLazzari]

New research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia. https://t.co/EOwzYNfpLb

[Gianpiero Lazzari @GpLazzari]

A new, faster and more reliable technique to revert human cells to the stem cell state has been developed. https://t.co/ATjwBLIOXf

[Gianpiero Lazzari @GpLazzari]

Cytiva and NecstGen collaborate to accelerate cell and gene therapy development in small to mid-sized enterprises and academic medical centers. Learn more: https://t.co/5Hi6LMrGXM

#celltherapy
#genetherapy
#lifesciences

[Gianpiero Lazzari @GpLazzari]

Learn how you can advance your expertise in cell and gene therapy. https://t.co/4QYWH404yo

#celltherapy
#lifesciences
#biotechnology

[Gianpiero Lazzari @GpLazzari]

#BREAKINGNEWS The demyelinating neurodegenerative disease multiple sclerosis (MS) is a complication of infection by the Epstein-Barr virus (EBV), suggests a new study. #MS #multiplesclerosis

https://t.co/SiR2bfnK3F

[Gianpiero Lazzari @GpLazzari]

“Being part of the NIIMBL community allows our company to be at the forefront of solving complex problems in automation; process analytical technologies; scale up and scale out; and process efficiencies. It’s an exciting collaboration.”

>>Learn more: https://t.co/jtf2VYF4Yb

[Gianpiero Lazzari @GpLazzari]

It's almost time for ESGCT congress!
Learn more on gene & cell therapy topics and visit our virtual booth!

Register here: https://t.co/EaSZsk3VCM

#genetherapy
#celltherapy

[Gianpiero Lazzari @GpLazzari]

Save the date! Meet Mike Paglia and Shannon Eaker who will share their perspectives on scaling-up and transitioning to cGMP manufacturing. Join us to learn more about reproducible and scalable manufacturing solutions for cell therapy. https://t.co/ry5TPRoli8

[Gianpiero Lazzari @GpLazzari]

@DgcbRetreat @ScielzoC @Cytiva @BDBiosciences It was a great moment of discussion and fruitful exchange!